Individual generic drug information
Extracted information for Glipizide only.
Type 2 diabetes mellitus ▶BY MOUTH ▶Adult: Initially 2.5–5 mg daily, adjusted according to response, dose to be taken shortly before breakfast or lunch, doses up to 15 mg may be given as a single dose, higher doses to be given in divided doses; maximum 20 mg per day
Source page 771
Sulfonylureas should be avoided where possible in Acute porphyrias p. 1120 but glipizide is thought to be safe.
Source page 771
Extracted information for Glipizide only.
→Appendix 1: sulfonylureas
Source page 771
▶Common or very common Abdominal pain upper ▶Uncommon Dizziness. drowsiness. tremor. vision disorders ▶Frequency not known Confusion. headache. hyponatraemia. malaise
Source page 771
The use of sulfonylureas in pregnancy should generally be avoided because of the risk of neonatal hypoglycaemia.
Source page 771
Avoid—theoretical possibility of hypoglycaemia in the infant.
Source page 771
Manufacturer advises caution in mild to moderate impairment. Dose adjustments Manufacturer advises consider initial dose of 2.5 mg daily and conservative maintenance dosing in mild to moderate impairment.
Source page 771
Extracted information for Glipizide only.
There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Glipizide (Non-proprietary) Glipizide 5 mg Glipizide 5mg tablets | 28 tablet P £3.34 DT = £2.53 | 56 tablet P £2.14–£6.20 ▶Minodiab (Pfizer Ltd) Glipizide 5 mg Minodiab 5mg tablets | 28 tablet P £1.26 DT = £2.53 eiiii F 747 Endocrine system
Source page 771
Filter the extracted dose blocks for this individual drug.
First line only; read the complete Indications and dose section above.
Initially 2.5–5 mg daily, adjusted according to
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 771
